Search Results - james+costello

1 Results

Sort By:

A novel treatment regimen for muscle-invasive bladder cancer.

Cisplatin(Cis)-based combination chemotherapy remains the standard of care for metastatic bladder cancer (BC) providing a 5-10% cure rate. Unfortunately up to 60% of patients are ineligible for Cis-based treatment and have the option for carboplatin(Carbo)-based combination chemotherapy. University of Colorado researchers, developed a novel therapy...

Published: 8/31/2022 | Inventor(s): James Costello

Disease Areas Oncology

Category(s): Therapeutics